Slide 1

West Midlands Academic Health Science Network Tony Davis West Midlands AHSN Slide 2 Background Innovation, Health & Wealth published December 11 set out a plan for spreading innovation through the NHS Focus that innovation is vital in order to transform healthcare Aim to rapidly spread change to improve quality, safety and productivity Slide 3 Role and purpose of AHSNs Improve the identification, adoption, spread, speed of innovation and good practice in the NHS Provide the opportunity to align education and training, clinical research, informatics, innovation and healthcare delivery Enable the NHS and academia to work collaboratively with industry Overall purpose to improve patient outcomes and create wealth Succeed where others have not Slide 4 West Midlands - background 5.6m diverse population Inequality in health outcomes and healthcare delivery Academic & clinical excellence, established regional networks and collaborations Industrial heritage that will drive wealth creation Slide 5 WM AHSN aims To transform the identification, adoption and spread of innovation and good practice To align healthcare delivery, research, education and training To drive wealth creation through the development of a regional industry portal enabling access to the NHS, driving adoption and publishing evaluation To improve outcomes Slide 6 Strategy & vision 6 enabling themes Develop a novel and comprehensive digital framework Establish regional clinical trials platforms - support for acceleration, reducing bureaucracy, improving efficiency and cost effectiveness To promote and accelerate innovation, evaluation and adoption To drive and develop patient-centric integrated care pathways - bridging primary, secondary & social care Focus on education & training - delivering a fit for purpose workforce in partnership with HEWM To create wealth - proactive support for regional medical technology industry engagement Slide 7 Initial focus on 3 clinical priorities Mental health In the young Dementia (carers, community management) Long Term Conditions Diabetes & obesity Musculoskeletal disease Drug safety From hospital to primary care Reducing prescribing errors across the region Slide 8 Organisations involved in AHSN development to date University Hospitals Coventry and Warwickshire NHS Trust University Hospitals Birmingham NHS Foundation Trust University of Birmingham Keele University Birmingham and Solihull Mental Health Foundation Trust University Hospital North Staffordshire NHS Trust University of Warwick Heart of England NHS Foundation Trust West Midlands South CLRN Medilink West Midlands Slide 9 Organisation & governance MEMBERS ownership and overall responsibility for the AHSN STAKEHOLDERS & PARTNERS sector cohesion via stakeholder reference groups BOARD leadership, strategy & assurance Independent Chair EXECUTIVE responsibility for the execution and delivery of the strategy Slide 10 Slide 11 AHSN board Chair MD COO Spoke chairs x 3 HEIs x 3 MH / community trust CEO Commercial representative LETB (non voting) CRN (non voting) Slide 12 AHSN Commissioning and Senate Reference Group Patients and Carers Reference Group Wider Stakeholder Group - LA, 3rd Sector Commercial & Industry Reference Group Slide 13 Current position Designated without condition on 13 th May 2013 (7 of the 15 AHSNs had conditions) 5.09 million funding for 2013/14 given in two parts Ensuring organisational form is fit for purpose with processes, structures and governance in place in order to be effective Stakeholder events for each theme and each spoke Defining our programmes of work and deliverables for each theme Slide 14 It must be remembered that there is nothing more difficult to plan, more doubtful of success, nor more difficult to manage than a new system. For the initiator has the challenge of all who would profit by the preservation of the old institution and merely lukewarm defenders in those who gain by the new ones. Machiavelli Slide 15 Our hope 5 years on To have an integrated & innovative health network not just in words To be the first UK regional digital healthcare economy To be the known place for industry for NHS access, evaluation and adoption To be significantly on the road to reversing health inequality and to have significantly improved outcomes for the region Slide 16 It is not the strongest or the most intelligent who will survive but those who can best manage change. Charles Darwin Slide 17 Questions?